Skip to main content
. 2020 Dec 4;23(2):117. doi: 10.3892/mmr.2020.11756

Figure 2.

Figure 2.

Successful establishment of the in vitro model of OA. CHON-001 cells were treated with IL-1β (10 ng/ml) for 24 h to establish an in vitro model of OA. Protein expression levels were (A) determined by western blotting, and (B) aggrecan and (C) MMP13 were semi-quantified. β-actin was used as an internal control. **P<0.01 vs. control group. IL-1β, interleukin-1β; OA, osteoarthritis.